After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...
Discoid lupus, the more common type ... The NHS also lists the following less common symptoms: headaches, mouth ulcers, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback